DNA FOUND IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES MAY NOT BE REQUIRED FOR INFECTIVITY

被引:32
|
作者
ARTS, EJ
MAK, J
KLEIMAN, L
WAINBERG, MA
机构
[1] MCGILL UNIV,JEWISH GEN HOSP,LADY DAVIS INST MED RES,MONTREAL H3T 1E2,PQ,CANADA
[2] MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,PQ,CANADA
来源
JOURNAL OF GENERAL VIROLOGY | 1994年 / 75卷
关键词
D O I
10.1099/0022-1317-75-7-1605
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have studied the presence and significance of retroviral genome-derived DNA in the core of human immunodeficiency virus (HIV) particles produced from transfections of HXB2 expression vectors in COS-7 cells and from HIV type 1 IIIB chronically infected H9 cells. Viruses purified by sucrose cushion centrifugation and treated with DNase I contained 1000-fold more viral RNA than DNA. However protease-defective viruses that contained only p160(gag-pol) had less than 100 times the amount of DNA in their cores than wild-type viruses suggesting that the p66/p51 form of reverse transcriptase was responsible for DNA transcription. Viruses produced by transfections in the presence of 3'-azido-3'-deoxythymidine (AZT) contained the viral RNA genome but only DNA of premature length because of the chain terminating effects of AZT. However such viruses were as infectious for CD4(+) cells as wild-type virus. We conclude that retrovirus-derived DNA in HIV-1 particles is not required for infection and does not play a significant role in this process.
引用
收藏
页码:1605 / 1613
页数:9
相关论文
共 50 条
  • [41] STIMULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY CERAMIDE
    PAPP, B
    ZHANG, DZ
    GROOPMAN, JE
    BYRN, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) : 775 - 780
  • [42] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    WEI, XP
    GHOSH, SK
    TAYLOR, ME
    JOHNSON, VA
    EMINI, EA
    DEUTSCH, P
    LIFSON, JD
    BONHOEFFER, S
    NOWAK, MA
    HAHN, BH
    SAAG, MS
    SHAW, GM
    NATURE, 1995, 373 (6510) : 117 - 122
  • [43] INFECTIOUS DECAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PLASMA
    MOUDGIL, T
    DAAR, ES
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01): : 210 - 212
  • [44] VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    SHAW, GM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S83 - S83
  • [45] QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION KINETICS
    DIMITROV, DS
    WILLEY, RL
    SATO, H
    CHANG, LJ
    BLUMENTHAL, R
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1993, 67 (04) : 2182 - 2190
  • [46] BASIC FEATURES OF THE NUCLEOCAPSID OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    DARLIX, JL
    ROQUES, BP
    M S-MEDECINE SCIENCES, 1993, 9 (8-9): : 952 - 958
  • [47] MOLECULAR INSIGHTS INTO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PATHOGENESIS
    FEINBERG, MB
    GREENE, WC
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 466 - 474
  • [48] MALIGNANCIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ARICO, M
    CASELLI, D
    DARGENIO, P
    DELMISTRO, AR
    DEMARTINO, M
    LIVADIOTTI, S
    SANTORO, N
    TERRAGNA, A
    CANCER, 1991, 68 (11) : 2473 - 2477
  • [49] HYDROXYCHLOROQUINE TREATMENT OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SPERBER, K
    LOUIE, M
    KRAUS, T
    PRONER, J
    SAPIRA, E
    LIN, S
    STECHER, V
    MAYER, L
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 622 - 636
  • [50] MUTATION IN THE PRIMER BINDING-SITE OF THE TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS GENOME AFFECTS VIRUS PRODUCTION AND INFECTIVITY
    NAGASHUNMUGAM, T
    VELPANDI, A
    GOLDSMITH, CS
    ZAKI, SR
    KALYANARAMAN, VS
    SRINIVASAN, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 4114 - 4118